1. Home
  2. TYRA vs CCU Comparison

TYRA vs CCU Comparison

Compare TYRA & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$26.04

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Compania Cervecerias Unidas S.A.

CCU

Compania Cervecerias Unidas S.A.

HOLD

Current Price

$12.07

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
CCU
Founded
2018
1850
Country
United States
Chile
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
TYRA
CCU
Price
$26.04
$12.07
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
11
2
Target Price
$47.50
$12.00
AVG Volume (30 Days)
630.1K
142.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.42
Revenue Next Year
N/A
$4.71
P/E Ratio
N/A
$18.35
Revenue Growth
N/A
N/A
52 Week Low
$9.96
$10.71
52 Week High
$40.65
$15.36

Technical Indicators

Market Signals
Indicator
TYRA
CCU
Relative Strength Index (RSI) 34.50 62.51
Support Level $24.77 $10.83
Resistance Level $32.82 $12.11
Average True Range (ATR) 1.75 0.35
MACD -0.67 0.05
Stochastic Oscillator 7.53 78.90

Price Performance

Historical Comparison
TYRA
CCU

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: